20 Approach to a Patient with WBC Disorders, Lymphadenopathy and Splenomegaly Flashcards
May be a benign incidental finding or a presenting sign of an underlying disease
Lymphadenopathy
Clinical approach to patients with lymphadenopathy
History and physical exam
Age
Lymph nodes
Lab investigation
Removal of senescent RBCs
Antibody synthesis
Removal of antibody coated bacteria and antibody coated blood cells
Spleen
Space between the spleen can go to, not where the spleen is normally located
Traube’s space
Common s/s of splenomegaly
Heaviness/LUQ fullness
Early satiety
Form of mucopolyssacharidosis or accumulation of GAGs
Gaucher’s disease
Neoplastic transformation of WBC precursors
Maturation arrest
Uncontrolled proliferation
Evasion of apoptosis
Condensed granules that look like sticks in the cytoplasm
Differentiation of leukemia
Auer rods
Nonspecific signs and symptoms as a consequence of cytopenias
Leukemia
Diagnosis of leukemia
Reads how many of the cells express a particular signature
Flow cytometry
Definitive Ags for AML
Cytoplasmic MPO
Definitive Ags for ALL T-cells
Cytoplasmic CD3
Surface CD3
T cell receptor CD7-bright
Strongly associated Ags with AML
CD117
Strongly associated Ags with ALL-B cell
Cytoplasmic CD79a
Cytoplasmic CD22, CD19, CD-10 bright
Strongly associated Ags with ALL-T cell
CD7 bright
Moderately associated Ags with AML
CD13
CD33
Moderately associated Ags with ALL-B cell
TdT-moderate to bright
Moderately associated Ags with ALL-T cell
CD5
CD2
Treatment modalities for leukemia
Transfusion (supportive)
Chemotherapy
Bone marrow transplant (curative)
TKI inhibitors for CML
Imatinib
Chromosomal aberration resulting in abnormal transcription factors that affect development of B and T cells
ALL
Chromosomal deletion or possible somatic hypermutation of postgerminal or naive B cells
CLL
Oncogenic mutations impede differentation, accumulating immature myeloid blasts in marrow
AML
Tyrosine kinase pathway related chromosomal translocation (Philadelphia chromosome)
CML
Immature B or T cell (marrow)
ALL
Peripheral B or T cell (lymph nodes)
CLL
Immature myeloid lineage cells (marrow)
AML
Pluripotent hematopoietic stem cell (marrow)
CML
Condensed chromatin, scant cytoplasm, small nucleoli
ALL
Smudge cells, condensed chromatin, scant cytoplasm
CML
Auer rods (abnormal lysosomes), myeloblasts, monoblasts
AML
Hypercellular marrow, elevated eosinophils and basophils
CML
Stormy onset, symptoms related to depressed marrow function, bone pain, CNS manifestations
ALL
Asymptomatic or nonspecific, LAD, hepatosplenomegaly
CLL
Anemia symptoms, spontaneous bleeding, petechiae and eccymoses
AML
Insidious onset, mild anemic symptoms, splelenomegaly
CML
Anemia, thrombocytopenia, variable WBC’s, >30% lymphoblasts
ALL
Sustained antibodies, lymphocytosis > 5000/uL, low platelets in 20-30%
CLL
Anemia, neutropenia, thrombocytopenia, >30% myeloblasts, auer rods
AML
Asymptomatic WBC > 50000
Symptomatic WBC > 200000-1000000, some blast forms, increased eosinophils and basophils
CML
Most common leukemia among children
ALL
Most common leukemia among adults, twice as common in men
CLL
Most common leukemia among adults
AML
Most common leukemia among ages 20-50, and rare in children
CML